BIO Events
BIO’s mission to Tokyo builds on fruitful cooperation
The BIO Delegation (pictured from left): Tasuku Kitada (Strand Therapeutics), Adam Roach (BeOne Medicines, formerly Beigene), Jacob Becraft (Strand Therapeutics), John F. Crowley (BIO), Eric ...
March 25, 2025
Read More
Latest News
Q1 roundup of state ag policy impacting biotech
May 1, 2025
BIO campaign urges: ‘Invest in America. Vaccinate’
April 28, 2025
BIO IP expert reviews the current policy landscape
April 26, 2025
Tariffs hurt growers and ag biotech, BIO says
April 14, 2025
LATEST STORIES
Health
Q1 roundup of state health policy impacting biotech
State legislatures remain busy across the country—especially when it comes to healthcare policy. As Q1 wraps up and we move into the mid-year, the Biotechnology ...
May 1, 2025
Agriculture
Q1 roundup of state ag policy impacting biotech
Agricultural legislative activity is proving to be busy this year for biotech as we move out of Q1 and into the summer. GMO labeling, animal ...
May 1, 2025
Federal Policy
Show Me the Evidence: Data to Understand and Break Down Patient Access Barriers!
“Data makes you credible; stories make you memorable,” began Amy Niles, Chief Mission Officer of the PAN Foundation, during the Biotechnology Innovation Organization’s (BIO) monthly ...
May 1, 2025
WHAT YOU MISSED AT THE LATEST BIO EVENTS
BIO’s mission to Tokyo builds on fruitful cooperation
The BIO Delegation (pictured from left): Tasuku Kitada (Strand Therapeutics), Adam Roach (BeOne Medicines, formerly Beigene), Jacob Becraft (Strand Therapeutics), John F. Crowley (BIO), Eric ...
March 25, 2025
Read More
M&A comeback may face political headwinds, say BIO CEO panelists
When it comes to biotech M&A, 2024 wasn’t a great year, but it wasn’t “horrible,” according to analysts at the BIO CEO & Investor Conference ...
February 18, 2025
Read More